We are live on ! Find out more
RCPI

ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI

Delisted

RCPI was delisted on the 4th of November, 2015.

Back to rankings

5 hedge funds and large institutions have $3.02K invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 3 → 5 (+2)

97% less capital invested

Capital invested by funds: $109K → $3.02K (-$106K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$196
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Kempner Capital Management
Texas
$2K – – –
Ameriprise
2
Ameriprise
Minnesota
$1K -$196 -18,140 -16%
WP
3
WealthPLAN Partners
Nebraska
$22 +$22 +1,936 New

RCPI Hedge Fund Activity: Q2 2016 in Review

5 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q2 2016, worth a combined $3.02K — down 97% from $109K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new RCPI positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest seller was Ameriprise, cutting an estimated $196.

  • 5 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q2 2016, up from 3 in Q1 2016.
  • Funds reported $3.02K of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q2 2016, down 97% quarter-over-quarter.
  • 2 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q2 2016 and 0 closed out, a net change of +2 holders.
  • The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q2 2016 was Ameriprise, an estimated $196 sold.

Based on aggregated 13F filings for Q2 2016.